1,333 Shares in Birkenstock Holding plc (NYSE:BIRK) Acquired by Headlands Technologies LLC

Headlands Technologies LLC purchased a new stake in shares of Birkenstock Holding plc (NYSE:BIRK) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,333 shares of the company’s stock, valued at approximately $76,000.

Several other institutional investors also recently bought and sold shares of the business. Quarry LP purchased a new position in shares of Birkenstock in the 3rd quarter valued at $25,000. Signaturefd LLC raised its position in Birkenstock by 642.6% in the fourth quarter. Signaturefd LLC now owns 505 shares of the company’s stock valued at $29,000 after purchasing an additional 437 shares during the period. Bank Julius Baer & Co. Ltd Zurich acquired a new position in shares of Birkenstock during the fourth quarter worth about $34,000. MetLife Investment Management LLC boosted its position in shares of Birkenstock by 52.2% in the third quarter. MetLife Investment Management LLC now owns 688 shares of the company’s stock worth $34,000 after buying an additional 236 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in shares of Birkenstock by 112.0% in the fourth quarter. JPMorgan Chase & Co. now owns 1,338 shares of the company’s stock valued at $76,000 after buying an additional 707 shares in the last quarter. 19.93% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on BIRK. Robert W. Baird boosted their price target on Birkenstock from $65.00 to $72.00 and gave the stock an “outperform” rating in a research report on Thursday, December 19th. UBS Group boosted their target price on shares of Birkenstock from $83.00 to $95.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Birkenstock from $65.00 to $66.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Telsey Advisory Group reissued an “outperform” rating and issued a $70.00 price objective on shares of Birkenstock in a research report on Thursday, February 20th. Finally, BTIG Research raised their target price on Birkenstock from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Wednesday, December 18th. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Birkenstock currently has a consensus rating of “Moderate Buy” and an average price target of $68.31.

Birkenstock Stock Performance

BIRK stock opened at $43.96 on Monday. The firm has a market cap of $8.26 billion, a P/E ratio of 35.45, a P/E/G ratio of 1.02 and a beta of 1.71. The stock’s 50 day simple moving average is $50.61 and its 200 day simple moving average is $51.58. The company has a current ratio of 2.84, a quick ratio of 1.08 and a debt-to-equity ratio of 0.48. Birkenstock Holding plc has a 12-month low of $41.00 and a 12-month high of $64.78.

Birkenstock (NYSE:BIRK) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.03. Birkenstock had a net margin of 11.73% and a return on equity of 9.52%. The company had revenue of $385.88 million for the quarter, compared to the consensus estimate of $355.80 million. As a group, equities research analysts predict that Birkenstock Holding plc will post 1.77 EPS for the current year.

Birkenstock Company Profile

Birkenstock Holding plc manufactures and sells footwear products. It also offers sandals, shoes, closed-toe silhouettes, skincare products, and accessories. The company sells its products through e-commerce sites and a network of owned retail stores, as well as business-to-business channels. It operates in the United States, Brazil, Canada, Mexico, Europe, APMA, and internationally.